Whether you're considering this medication for weight loss or diabetes management, understanding the right dosage is key
Physician-led plans, built around your goals
This figure is directly comparable to the performance of tirzepatide (Mounjaro) in the SURMOUNT-1 trial, which showed approximately 20.9% weight loss at 72 weeks, and exceeds the approximately 14.9% achieved by semaglutide alone in STEP 1
02 Batch-focused review Purity, mass, sterility, and product details are maintained with care
TRT is generally a long-term treatment for men with clinically low testosterone, as levels often return to baseline if therapy is discontinued
These effects typically resolve as your body becomes accustomed to the medication